Crizotinib in anaplastic lymphoma kinase-positive anaplastic large cell lymphoma in the setting of renal insufficiency: a case report

Lymphoma

Primary Cutaneous Anaplastic Lymphoma Kinase-Positive Large B-Cell Lymphoma

Am J Dermatopathol.

Kempf W, Torricelli R, Zettl A, Zimmermann AK, Berisha A, Ghielmini M

doi: 10.1097/DAD.

Lung, Respiratory and Thoracic Cancer

First-line treatment of ALK-positive NSCLC

healthbook TIMES Oncology Hematology

Bouchaab H

doi: 10.36000/hbT.OH.2019.02.008

Lymphoma

CD19-Directed CAR T Cells Treatment in a Patient With Refractory DLBCL and CNS Involvement

healthbook TIMS Oncology Hematology

Ring A, Müller A

doi: 10.36000/hbT.OH.2019.01.005

Lymphoma

Cerebellar large B-cell lymphoma: a case report

doi: 10.1186/s13256-018-1880-z.

Lymphoma

Non-implant associated primary cutaneous anaplastic large cell lymphoma of the breast

J Surg Case Rep.

Bergsten TM, Principe DR, Raicu A, Rubin J, Ong AL, Hagen C

doi: 10.1093/jscr/rjz139.

Lymphoma

Anti-CD19 CAR T Cells in CNS Diffuse Large-B-Cell Lymphoma

N Engl J Med.

Abramson JS, McGree B, Noyes S, Plummer, S, Wong C, Chen Y, Palmer E, Albertson T, Ferry JA, Arrillaga-Romany IC

doi: 10.1056/NEJMc1704610.

Lymphoma

Rituximab-dose-dense chemotherapy with or without high-dose chemotherapy plus autologous stem-cell transplantation in high-risk diffuse large B-cell lymphoma (DLCL04): final results of a multicentre, open-label, randomised, controlled, phase 3 study

Lancet Oncol.

Chiappella A, Martelli M, Angelucci E, Brusamolino E, Evangelista A, Carella AM, Stelitano C, Rossi G, Balzarotti M, Merli F, Gaidano G, Pavone V, Rigacci L, Zaja F, D'Arco A, Cascavilla N, Russo E, Castellino A, Gotti M, Congiu AG, Cabras MG, Tucci A, Agostinelli C, Ciccone G, Pileri SA, Vitolo U

doi: 10.1016/S1470-

Lymphoma

A case report of unusually long lag time between immunotactoid glomerulopathy (itg) diagnosis and diffuse large B-cell lymphoma (DLBCL) development

BMC Nephrol.

Khandelwal A, Trinkaus MA, Ghaffar H, Jothy S, Goldstein MB

doi: 10.1186/s12882-016-0349-9.

Lymphoma

Hodgkin’s Lymphoma after Autologous Stem-Cell Transplantation: Effective Consolidation with Brentuximab Vedotin

healthbook Times Oncology Hematology

Schmidt A

doi: 10.36000/hbT.OH.2020.06.025

Related content

Primary Cutaneous Anaplastic Lymphoma Kinase-Positive Large B-Cell Lymphoma

First-line treatment of ALK-positive NSCLC

CD19-Directed CAR T Cells Treatment in a Patient With Refractory DLBCL and CNS Involvement

Cerebellar large B-cell lymphoma: a case report

Non-implant associated primary cutaneous anaplastic large cell lymphoma of the breast

Anti-CD19 CAR T Cells in CNS Diffuse Large-B-Cell Lymphoma

Rituximab-dose-dense chemotherapy with or without high-dose chemotherapy plus autologous stem-cell transplantation in high-risk diffuse large B-cell lymphoma (DLCL04): final results of a multicentre, open-label, randomised, controlled, phase 3 study

A case report of unusually long lag time between immunotactoid glomerulopathy (itg) diagnosis and diffuse large B-cell lymphoma (DLBCL) development

Hodgkin’s Lymphoma after Autologous Stem-Cell Transplantation: Effective Consolidation with Brentuximab Vedotin